文献速递血液淋巴病理

癌症生物标志物第五部分:B细胞淋巴瘤生物标志物更新

Cancer Biomarkers V: Update on B-Cell Lymphoma Biomarkers.
PubMed 文献 · Arch Pathol Lab Med · 2024-01-01

本文基于2022年9月癌症生物标志物会议内容,综述世界卫生组织与国际共识分类新近发布的B细胞淋巴瘤诊断指南及相关文献,强调病理学家在标本有限时优化检测以支持诊断、预后与治疗选择,并指出此类会议有助于推动患者管理与协作研究。

要点

  • 病理学家需在标本有限时优化B细胞淋巴瘤生物标志物检测以指导诊疗。
  • 细胞遗传学异常、特定突变、形态学特征和蛋白表达可辅助临床决策。
  • 世界卫生组织与国际共识分类新近发布了B细胞淋巴瘤诊断相关指南。

核心结论

  • 癌症生物标志物会议有助于提升对B细胞淋巴瘤生物标志物临床应用的认识并促进协作。

研究设计与样本

  • 综述性总结,基于世界卫生组织与国际共识分类新近发布的B细胞淋巴瘤诊断指南及相关文稿,并汇总2022年9月会议报告内容。

临床怎么用

  • 病理学家应关注B细胞淋巴瘤诊断、预后与治疗相关生物标志物的更新,并在标本有限时合理优化检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Pathologists play an increasingly critical role in optimizing testing on scant specimens to ensure patients not only receive a correct and timely diagnosis, but also that the appropriate evaluation of biologic markers, or "biomarkers," is performed to inform prognosis and best guide therapeutic options. Advances in biomarkers have been particularly impactful in the field of hematopathology, where the identification of cytogenetic abnormalities, specific mutations, morphologic features, and/or protein expression may help guide clinical decision-making, including type and intensity of therapy and eligibility for clinical trials. OBJECTIVE: To stay up to date with advances in relevant biomarkers for diagnosis, prognosis, and therapy. The Cancer Biomarkers Conference (CBC) has been developed as a highly focused meeting to provide key biomarker updates across medical fields with the inclusion of industry partners, to reach a broader audience, and cross-pollinate emerging areas for biomarker application and future discovery. The objective of this article is to raise awareness of the potential utility of such meetings for improving patient care and facilitating collaboration. DATA SOURCES: Recently released guidelines related to B-cell lymphoma diagnosis from the World Health Organization and International Consensus Classification and associated manuscripts are reviewed. Material presented at the CBC conference is summarized. CONCLUSIONS: This article covers highlights of the updates presented on B-cell lymphoma biomarkers at the most recent Cancer Biomarkers Conference in Flowood, Mississippi, in September 2022.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Crane GM. Cancer Biomarkers V: Update on B-Cell Lymphoma Biomarkers. Arch Pathol Lab Med. 2024. PMID: 37776258. doi:10.5858/arpa.2023-0056-RA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。